FDA Warns Indian Pharma Lupin on Repeated Quality Violations
An employee holds Ramipril capsules for a photograph inside a coating unit at the Lupin Ltd. pharmaceutical plant in Salcette, Goa, India. (Photographer: Dhiraj Singh/Bloomberg)

FDA Warns Indian Pharma Lupin on Repeated Quality Violations

Bookmark
(Bloomberg) -- Lupin Ltd., which makes generic antibiotics, antidepressants and heart medications for sale in the U.S., was warned by the Food and Drug Administration for repeatedly ignoring tests ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.